吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Feb 11 2019

Full Issue

Evidence Emerges That Promising Flu Killer Drug Doesn't Work Well For Some Patients

A mutant viral strain can stop the anti-flu medication Xofluza from working. Other public health news reported over the weekend covers depression, mental health struggles, gene-edited babies, anti-aging research, medication dosages for kids, hospital toxic waste, multiple sclerosis and more.

A new pill that can kill the flu virus in 24 hours with a single dose has become the most-prescribed influenza treatment in Japan, which is suffering through its worst flu season in two decades. But some doctors are backing away from the drug after new evidence emerged about mutant viral strains that prevent it from working well in some patients. The pill, called Xofluza, was discovered by Osaka-based Shionogi 4507 & Co., and it was approved last year by regulators in Japan and the U.S. In the U.S., it is marketed by Roche Holding AG鈥檚 Genentech unit. (Fujikawa and Davis, 2/11)

In a scenario playing out in more and more classrooms around the world, a Dallas teenager recently asked her classmate if anything was wrong, noting that she hadn't been acting like herself. The brusque reply: "Just leave me alone." The ninth-graders at the Uplift Hampton Preparatory school were role-playing as part of a program that aims to teach teens how to spot the signs of depression in themselves and others. (2/9)

Jason Reeves, 32, struggled for years to find his way, frequently running afoul of the law and grappling with mental health issues. In spite of it all, his mother, Paulette, stood by him, trying to help her son climb out of his personal morass. This month, everything came crashing down. (Winston, 2/10)

He is famous for his founding roles at Facebook and Napster, but these days the billionaire philanthropist Sean Parker is turning his attention to fighting cancer. Three years ago, he announced a $250 million investment to build teams of scientists for immunotherapy research, one of the hottest fields in taking on cancer. In an interview with STAT last week in his hotel suite overlooking Central Park, Parker spoke intensely about his belief that the government needs to move far more aggressively in investing in biotech, life sciences, and health care. (Berke, 2/11)

Kaiser Health News: A 鈥楩ountain Of Youth鈥 Pill? Sure, If You鈥檙e A Mouse.

Renowned Harvard University geneticist David Sinclair recently made a startling assertion: Scientific data shows he has knocked more than two decades off his biological age. What鈥檚 the 49-year-old鈥檚 secret? He says his daily regimen includes ingesting a molecule his own research found improved the health and lengthened the life span of mice. Sinclair now boasts online that he has the lung capacity, cholesterol and blood pressure of a 鈥測oung adult鈥 and the 鈥渉eart rate of an athlete.鈥 (Taylor, 2/11)

It's the middle of the night and you wake up to the disturbing sound of your little one crying and sniffling with a cold, sore throat or fever. And, if you're like many parents, you reach into the medicine cabinet, seeking some relief. But giving medication 鈥 and getting the dose right 鈥 can be more challenging than you might think. Jesse and Shannan Ridall live in Palmyra, Pa., with their three young children. Jesse says the lined markings on dosing devices of children's medicine can be confusing, especially when they show both teaspoons and milliliters. (Neighmond, 2/11)

It was an ironic discovery: Medical centers designed to treat patients could actually be harming them. In 1994, the Environmental Protection Agency released a report that found that incinerators used by many hospitals throughout the United States were a top of emitter of harmful air pollutants, including mercury and dioxin. (Vinopal, 2/8)

How close is a cure for multiple sclerosis? That鈥檚 difficult to answer: Researchers are still working hard to understand the potentially disabling disease. But MS studies are growing. In 2018, the term 鈥渕ultiple sclerosis鈥 appeared in the titles of more than 3,000 articles in PubMed, the U.S. National Library of Medicine鈥檚 search engine for academic research on life sciences and biomedical topics. That鈥檚 a torrent of information. (Blakemore, 2/10)

The past three decades have seen a drop in the number of nonsmokers who are exposed to secondhand smoke, but those numbers are no longer declining, according to new data from the Centers for Disease Control and Prevention. About 58 million American nonsmokers 鈥 or 1 in 4 鈥 were exposed to secondhand smoke from 2013鈥2014, the CDC said. (Washington, 2/11)

Sometimes it takes the licensing and advertising of a treatment to get patients to seek help, even for a medical problem that is often painful and psychologically devastating. Such is the case with Peyronie鈥檚 disease, a scarring and bending or curving of the penis that can make sexual intercourse difficult or impossible for both straight and gay men. It most often afflicts middle-aged men, usually the result of an injury that may not have been noticed. Injury can occur during a sports activity, accident or vigorous sex when the erect penis is bent or pounded against bone. (Brody, 2/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 7
  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF